China's approvals for innovative drugs have reached new highs, with the scale of out-licensing deals in the first half of the year nearly matching the total for all of last year.
Impact
8/100
Current rank score
6.38
Source tier
Tier 2
Category
Product
Firefly links to the original publisher. The summary above is AI-generated for orientation and may differ from the source. The “current rank score” decays over time so newer significant stories surface first.